Dr. Joseph J. Fanciullo, MD

Dr. Fanciullo practices at Avera Medical Group Rheumatology Sioux Falls in Sioux Falls, South Dakota.

Dr. Fanciullo's NPI, 1437182516, was assigned on July 9, 2006. Dr. Fanciullo graduated from University of Nebraska College of Medicine in 1992. Dr. Fanciullo holds South Dakota license 4251.

Dr. Fanciullo's primary practice is Avera Medical Group Rheumatology Sioux Falls, at 1301 S Cliff Ave, Sioux Falls, SD 57105 in Minnehaha County. The practice phone is (605) 504-1600.

Dr. Fanciullo's primary practice is Avera Medical Group Rheumatology Sioux Falls in Sioux Falls, South Dakota. Dr. Fanciullo is also affiliated with Avera McKennan Hospital & University Health Center. The medical group on file is Avera McKennan Hospital & University Health Center. Dmand AI also links Dr. Fanciullo to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fanciullo practices, 6 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Fanciullo's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Fanciullo is licensed in South Dakota.

CMS data shows 522 Medicare services from Dr. Fanciullo across 3 procedure codes in 2024, all of them office visits, for 325 Medicare patients. Medicare paid $28,283 for them. Every service was in an office.

CMS counts 325 Medicare patients who saw Dr. Fanciullo in 2024. The largest group is 65 to 74, with 168 patients. 75% of them have arthritis, and 69% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Fanciullo's median patient age at 68, with 74% women.

In 2024, Dr. Fanciullo wrote 2,791 Medicare Part D claims for 324 patients. 78% of them were for generic drugs. CMS names the drug for 2,687 of them, across 32 drugs with 11 or more claims each, at $2,552,597 in total drug cost. In 2023, CMS named 2,580 claims across 35 drugs.

Dr. Fanciullo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fanciullo as offering telehealth.

Dmand AI links 12 papers to Dr. Fanciullo, published from 2018 to 2023. The most frequent topics are Arthritis, Rheumatoid, Genotype and Hydroxymethylglutaryl-CoA Reductase Inhibitors. Dr. Fanciullo has published most often in S D Med. Dr. Fanciullo's most frequent co-authors are Touba Naim, MD, Abdelmohaymin Abdalla Abufatima Abdalla, MD and Matthew Don Jahraus, DO.

CMS Open Payments shows 17 general payments to Dr. Fanciullo from 10 drug and device companies from 2017 to 2025. Education make up the largest share, 50% of the total. Janssen Pharmaceuticals, Inc paid the most, $193.

Dr. Fanciullo graduated from University of Nebraska College of Medicine in 1992.